CLINICAL_TRIALS ClinicalTrials.gov record update

24-week, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Exelon® [Rivastigmine] Transdermal Patch in 120 APOE e4 Positive Amnestic MCI Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01602198
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:16.782201+00:00
Published At: 2017-02-28T00:00:00+00:00
Record Updated At: 2017-02-28
Results Posted At: 2017-02-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Mild Cognitive Disorder", "Mild Cognitive Impairment"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-02-28"
protocolSection.identificationModule.nctId: "NCT01602198"
protocolSection.identificationModule.officialTitle: "24-week, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Exelon\u00ae [Rivastigmine] Transdermal Patch in 120 APOE e4 Positive Amnestic MCI Patients"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-02-28"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.